Variant report

Variant	nsv1868
Chromosome Location	chr16:72801962-72820054
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:109)
CpG islands
(count:123)
Chromatin interactive
region (count:9)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:4)

(count:109 , 50 per page) page: 1 2 3

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr16:72808355-72808483	K562	blood:	n/a	n/a
2	CEBPB	chr16:72808259-72808532	HepG2	liver:	n/a	n/a
3	CTCF	chr16:72818120-72818270	HMF	breast:	n/a	n/a
4	CTCF	chr16:72817980-72818130	HPAF	blood vessel:	n/a	n/a
5	CTCF	chr16:72818100-72818250	HCFaa	heart:	n/a	n/a
6	CTCF	chr16:72804700-72804850	Hela-S3	cervix:	n/a	n/a
7	E2F4	chr16:72803874-72804137	MCF10A-Er-Src	breast:	n/a	n/a
8	EBF1	chr16:72817905-72818160	GM12878	blood:	n/a	n/a
9	EBF1	chr16:72817848-72818146	GM12878	blood:	n/a	n/a
10	EP300	chr16:72817907-72817919	GM12878	blood:	n/a	n/a
11	FOS	chr16:72803804-72804150	MCF10A-Er-Src	breast:	n/a	n/a
12	FOS	chr16:72803790-72804126	MCF10A-Er-Src	breast:	n/a	n/a
13	FOS	chr16:72803828-72804150	MCF10A-Er-Src	breast:	n/a	n/a
14	FOSL2	chr16:72813727-72814360	HepG2	liver:	n/a	n/a
15	FOSL2	chr16:72815348-72815903	HepG2	liver:	n/a	n/a
16	FOSL2	chr16:72814698-72815194	HepG2	liver:	n/a	n/a
17	FOXA1	chr16:72817614-72817906	T-47D	breast:	n/a	n/a
18	FOXA1	chr16:72817627-72817871	T-47D	breast:	n/a	n/a
19	FOXA1	chr16:72817566-72818026	HepG2	liver:	n/a	n/a
20	FOXA1	chr16:72817534-72818008	HepG2	liver:	n/a	n/a
21	FOXA1	chr16:72817490-72817907	HepG2	liver:	n/a	n/a
22	FOXA1	chr16:72817535-72818073	HepG2	liver:	n/a	n/a
23	FOXA2	chr16:72817279-72818166	HepG2	liver:	n/a	n/a
24	FOXA2	chr16:72817654-72817947	HepG2	liver:	n/a	n/a
25	FOXA2	chr16:72817516-72818096	A549	lung:	n/a	n/a
26	GATA3	chr16:72816490-72816613	SH-SY5Y	brain:	n/a	n/a
27	GATA3	chr16:72812878-72812930	SH-SY5Y	brain:	n/a	n/a
28	GATA3	chr16:72817584-72817917	T-47D	breast:	n/a	n/a
29	GATA3	chr16:72817634-72817969	T-47D	breast:	n/a	n/a
30	IRF1	chr16:72819834-72820150	K562	blood:	n/a	n/a
31	MAFF	chr16:72805857-72806054	HepG2	liver:	n/a	chr16:72805949-72805967
32	MAFF	chr16:72806560-72806816	HepG2	liver:	n/a	chr16:72806669-72806687
33	MAFK	chr16:72805932-72806136	HepG2	liver:	n/a	n/a
34	MAFK	chr16:72806631-72806762	IMR90	lung:	n/a	n/a
35	MAFK	chr16:72806536-72806834	HepG2	liver:	n/a	n/a
36	MAFK	chr16:72806549-72806814	HepG2	liver:	n/a	n/a
37	MYC	chr16:72814166-72814347	H1-hESC	embryonic stem cell:	n/a	n/a
38	MYC	chr16:72803279-72803330	NB4	blood:	n/a	n/a
39	NFYB	chr16:72805797-72806313	K562	blood:	n/a	n/a
40	NFYB	chr16:72805800-72806128	GM12878	blood:	n/a	n/a
41	POLR2A	chr16:72809531-72809651	HUVEC	blood vessel:	n/a	n/a
42	POLR2A	chr16:72810441-72812106	H1-neurons	neurons:	n/a	n/a
43	POLR2A	chr16:72819062-72819477	H1-neurons	neurons:	n/a	n/a
44	POLR2A	chr16:72816662-72816700	ProgFib	skin:	n/a	n/a
45	POLR2A	chr16:72812938-72813268	MCF-7	breast:	n/a	n/a
46	POLR2A	chr16:72812359-72816388	H1-neurons	neurons:	n/a	n/a
47	POLR2A	chr16:72813909-72814610	MCF-7	breast:	n/a	n/a
48	POLR2A	chr16:72813817-72814415	HepG2	liver:	n/a	n/a
49	POLR2A	chr16:72815111-72815119	Hela-S3	cervix:	n/a	n/a
50	POLR2A	chr16:72813076-72813160	Hela-S3	cervix:	n/a	n/a

(count:123 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:72819254-72819304	Hepatocyte	liver:	n/a
2	chr16:72819254-72819304	Hepatocyte	liver:	n/a
3	chr16:72819254-72819304	SAEC	small airway:	n/a
4	chr16:72819254-72819304	BJ	skin:	n/a
5	chr16:72817808-72817858	SK-N-SH	brain:	n/a
6	chr16:72817808-72817858	HCPEpiC	choroid plexus:	n/a
7	chr16:72819254-72819304	BE2_C	brain:	n/a
8	chr16:72817808-72817858	PFSK-1	brain:	n/a
9	chr16:72817808-72817858	SK-N-MC	brain:	n/a
10	chr16:72817808-72817858	NH-A	brain:	n/a
11	chr16:72819254-72819304	HPAEpiC	pulmonary alveolar:	n/a
12	chr16:72817808-72817858	MCF10A-Er-Src	breast:	n/a
13	chr16:72817808-72817858	HIPEpiC	eye:	n/a
14	chr16:72819254-72819304	Hela-S3	cervix:	n/a
15	chr16:72817808-72817858	MCF-7	breast:	n/a
16	chr16:72817808-72817858	AG04450	lung:	fetal
17	chr16:72817808-72817858	AG09319	gingival:	n/a
18	chr16:72819254-72819304	AG04450	lung:	fetal
19	chr16:72817808-72817858	GM19239	blood:	n/a
20	chr16:72817808-72817858	U87	brain:	n/a
21	chr16:72817808-72817858	H1-hESC	embryonic stem cell:	embryo
22	chr16:72817808-72817858	HCT-116	colon:	n/a
23	chr16:72819254-72819304	ProgFib	skin:	n/a
24	chr16:72817808-72817858	HEK293	kidney:	embryo
25	chr16:72817808-72817858	AG04449	skin:	fetal
26	chr16:72817808-72817858	HRCEpiC	kidney:	n/a
27	chr16:72819254-72819304	MCF10A-Er-Src	breast:	n/a
28	chr16:72819254-72819304	HEK293	kidney:	embryo
29	chr16:72819254-72819304	HRPEpiC	eye:	n/a
30	chr16:72817808-72817858	Jurkat	blood:	n/a
31	chr16:72819254-72819304	SK-N-SH	brain:	n/a
32	chr16:72819254-72819304	NT2-D1	testis:	n/a
33	chr16:72817808-72817858	HAEpiC	amniotic membrane:	n/a
34	chr16:72819254-72819304	T-47D	breast:	n/a
35	chr16:72819254-72819304	K562	blood:	n/a
36	chr16:72817808-72817858	HPAEpiC	pulmonary alveolar:	n/a
37	chr16:72817808-72817858	HRPEpiC	eye:	n/a
38	chr16:72819254-72819304	SK-N-SH_RA	brain:	n/a
39	chr16:72817808-72817858	ECC-1	luminal epithelium:	n/a
40	chr16:72819254-72819304	AG04449	skin:	fetal
41	chr16:72817808-72817858	GM12892	blood:	n/a
42	chr16:72817808-72817858	HCM	heart:	n/a
43	chr16:72819254-72819304	ECC-1	luminal epithelium:	n/a
44	chr16:72817808-72817858	GM06990	blood:	n/a
45	chr16:72819254-72819304	GM19239	blood:	n/a
46	chr16:72817808-72817858	K562	blood:	n/a
47	chr16:72817808-72817858	SKMC	muscle:	n/a
48	chr16:72817808-72817858	LNCaP	prostate:	n/a
49	chr16:72817808-72817858	SK-N-SH_RA	brain:	n/a
50	chr16:72817808-72817858	HEEpiC	esophagus:	n/a

(count:9 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr16:72800047..72802157-chr16:72806657..72808426,2	MCF-7	breast:
2	chr16:72808782..72811039-chr16:73094813..73097689,2	MCF-7	breast:
3	chr16:72804678..72807227-chr16:72810442..72813074,3	K562	blood:
4	chr16:72800047..72802157-chr16:72806657..72808426,2	MCF-7	breast:
5	chr16:72794483..72797300-chr16:72799955..72802337,2	MCF-7	breast:
6	chr16:72804678..72807227-chr16:72810442..72813074,3	K562	blood:
7	chr16:72810272..72812904-chr16:72814372..72816078,2	MCF-7	breast:
8	chr16:72796830..72798395-chr16:72801602..72803479,2	K562	blood:
9	chr16:72810272..72812904-chr16:72814372..72816078,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZFHX3-1	chr16:72806574-72807222	l_1360_chr16:72783804-72807057_testes
2	lnc-DHX38-4	chr16:72815627-72815718	ENSG00000259768.3
3	lnc-ZFHX3-1	chr16:72807234-72807445	l_1360_chr16:72783804-72807057_testes

No data

(count:4 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location
1	ZFHX3	hsa-miR-16-5p	chr16:72819092-72819112
2	ZFHX3	hsa-miR-340-5p	chr16:72818210-72818230
3	ZFHX3	hsa-miR-181b-5p	chr16:72817458-72817480
4	ZFHX3	hsa-miR-16-5p	chr16:72819098-72819091

Variant related genes	Relation type
ENSG00000259901	TF binding region
ENSG00000259901	CpG island

Extended variants
information (count: 602 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:602 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4238966	chr16:72801982-72801983	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs558478344	chr16:72801990-72801991	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs576350294	chr16:72802023-72802024	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs200965409	chr16:72802045-72802046	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs534722633	chr16:72802060-72802061	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs374069031	chr16:72802061-72802062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs543873531	chr16:72802142-72802143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs562142353	chr16:72802147-72802148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs529379086	chr16:72802204-72802205	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs149003964	chr16:72802310-72802311	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs189355018	chr16:72802379-72802380	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs79794606	chr16:72802404-72802405	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs182192964	chr16:72802423-72802424	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs552385145	chr16:72802448-72802449	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs186407537	chr16:72802455-72802456	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs530401596	chr16:72802475-72802476	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs548538268	chr16:72802476-72802477	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs566935751	chr16:72802526-72802527	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs371973645	chr16:72802541-72802542	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs368542049	chr16:72802553-72802554	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs559174214	chr16:72802615-72802616	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs528236706	chr16:72802632-72802633	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs564188667	chr16:72802637-72802638	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs201785948	chr16:72802649-72802650	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs201694672	chr16:72802664-72802665	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs558152996	chr16:72802689-72802690	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs138638431	chr16:72802714-72802715	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs537762788	chr16:72802769-72802770	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs555765059	chr16:72802770-72802771	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs547988401	chr16:72802783-72802784	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs574085509	chr16:72802792-72802793	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs190806997	chr16:72802853-72802854	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs559836419	chr16:72802912-72802913	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs577746677	chr16:72802963-72802964	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs372712079	chr16:72802966-72802967	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs141526833	chr16:72802979-72802980	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs35212471	chr16:72802984-72802985	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs545215251	chr16:72803037-72803038	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs563358813	chr16:72803060-72803061	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs60974482	chr16:72803084-72803085	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs141266929	chr16:72803129-72803130	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs116932646	chr16:72803130-72803131	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs528124778	chr16:72803156-72803157	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs546370842	chr16:72803206-72803207	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs59254438	chr16:72803221-72803222	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs35870527	chr16:72803321-72803322	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs550838980	chr16:72803324-72803325	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs539624385	chr16:72803328-72803329	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs146948800	chr16:72803339-72803340	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs570278758	chr16:72803353-72803354	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute myeloid leukemia	16864856	CNVD
Infiltrating lobular breast cancer	19191266	CNVD
T-cell lymphomas	19863542	CNVD
Hepatocellular carcinoma	16750200	CNVD
Medulloblastoma	16783165	CNVD
Neuroblastoma	21899760	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	18628472	CNVD
Breast cancer	21806811	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21509527	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Ependymoma	18628472	CNVD
Ewing''s sarcoma	18628472	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:212 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:72783800-72810600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
2	chr16:72793600-72802400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr16:72794800-72818000	Weak transcription	Aorta	Aorta
4	chr16:72795400-72802400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
5	chr16:72798000-72802200	Weak transcription	HUES48 Cell Line	embryonic stem cell
6	chr16:72798200-72802800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
7	chr16:72798400-72802200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
8	chr16:72798400-72802400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
9	chr16:72798400-72802400	Weak transcription	HUES6 Cell Line	embryonic stem cell
10	chr16:72798400-72802400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
11	chr16:72798400-72817800	Weak transcription	HSMM	muscle
12	chr16:72798800-72802400	Weak transcription	Fetal Kidney	kidney
13	chr16:72798800-72815600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
14	chr16:72800600-72802600	Weak transcription	HUES64 Cell Line	embryonic stem cell
15	chr16:72801000-72808000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr16:72802200-72803400	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr16:72802200-72803400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr16:72802400-72802600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
19	chr16:72802400-72802800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
20	chr16:72802400-72803000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
21	chr16:72802400-72803000	Enhancers	Primary hematopoietic stem cells	blood
22	chr16:72802400-72803200	Enhancers	Fetal Kidney	kidney
23	chr16:72802400-72803400	Enhancers	H9 Cell Line	embryonic stem cell
24	chr16:72802400-72803400	Enhancers	HUES6 Cell Line	embryonic stem cell
25	chr16:72802400-72803400	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr16:72802400-72803400	Enhancers	Primary hematopoietic stem cells short term culture	blood
27	chr16:72802400-72803600	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr16:72802400-72803600	Enhancers	iPS-20b Cell Line	embryonic stem cell
29	chr16:72802400-72803600	Enhancers	Primary T cells from cord blood	blood
30	chr16:72802600-72803200	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr16:72802600-72803400	Enhancers	iPS-18 Cell Line	embryonic stem cell
32	chr16:72802600-72803600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
33	chr16:72802800-72803400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr16:72803000-72803400	Enhancers	H1 Cell Line	embryonic stem cell
35	chr16:72803000-72803400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr16:72803000-72811200	Weak transcription	Primary hematopoietic stem cells	blood
37	chr16:72803400-72808800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
38	chr16:72803600-72805400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
39	chr16:72803600-72809800	Weak transcription	Primary T cells from cord blood	blood
40	chr16:72805400-72805800	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell
41	chr16:72805600-72806400	ZNF genes & repeats	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr16:72806200-72806400	ZNF genes & repeats	Fetal Intestine Small	intestine
43	chr16:72806400-72809400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
44	chr16:72806400-72820600	Weak transcription	Fetal Intestine Small	intestine
45	chr16:72809600-72810000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr16:72810000-72810400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr16:72810200-72821800	Weak transcription	Dnd41	blood
48	chr16:72810400-72810600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr16:72810400-72811000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
50	chr16:72810600-72810800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links